论文信息 - Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study - 字舞流文

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study

D. Esseltine | H. van de Velde | P. Moreau | X. Leleu | B. Arnulf | W. Deraedt | Huaibao Feng | P. Robak | H. Pylypenko | S. Grosicki | Ievgenii Karamanesht | G. Rekhtman | Z. Masliak | H. V. D. van de Velde